Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 200
Filtrar
1.
Eur J Prosthodont Restor Dent ; 32(1): 56-64, 2024 Feb 29.
Artículo en Inglés | MEDLINE | ID: mdl-37721553

RESUMEN

INTRODUCTION: The association of the periodontium with the fixed prosthesis is the basis of prosthetic rehabilitation. This prospective case series aimed to evaluate periodontal health through the relation between periodontal/peri-implant disease progression and the use of fixed partial dentures (FPDs). METHODS: Probing depth (PD), clinical attachment level (CAL), gingival index (GI), and plaque index (PI) on either teeth or implants were evaluated at up to 25-year follow-up and compared with the baseline. Statistical analysis was performed using the Kaplan-Meier test (p⟨0.05). RESULTS: The prospective evaluation showed that the patients maintained adequate periodontal health. Failure (severe periodontal stages) occurred in 12.5% of patients. The survival rate for 107 teeth/implants was 80.48%. The comparisons for clinical parameters revealed no statistically significant difference (p⟩ 0.05). At T1, the measurements for anterior and posterior regions, respectively, were PD =2.7mm and 3.1mm; CAL= 3.3mm and 3.6mm; GI=0.5 (both regions); and PI=0.79 and 0.62. Periodontal/peri-implant disease progression did not relate to the use of prostheses. CONCLUSIONS: Patients with more frequent follow-up appointments and lower GI and PI showed periodontal health for longer periods. Patients with different oral hygiene levels present different periodontal disease progression. Periodic hygiene control and motivation are vital factors for extensive oral rehabilitation success.


Asunto(s)
Implantes Dentales , Periimplantitis , Enfermedades Periodontales , Humanos , Implantes Dentales/efectos adversos , Enfermedades Periodontales/inducido químicamente , Dentadura Parcial Fija , Estudios de Seguimiento
2.
Environ Geochem Health ; 45(11): 8187-8202, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37552412

RESUMEN

We aimed to characterize the association between air pollutants exposure and periodontal diseases outpatient visits and to explore the interactions between ambient air pollutants and meteorological factors. The outpatient visits data of several large stomatological and general hospitals in Hefei during 2015-2020 were collected to explore the relationship between daily air pollutants exposure and periodontal diseases by combining Poisson's generalized linear model (GLMs) and distributed lag nonlinear model (DLNMs). Subgroup analysis was performed to identify the vulnerability of different populations to air pollutants exposure. The interaction between air pollutants and meteorological factors was verified in both multiplicative and additive interaction models. An interquartile range (IQR) increased in nitrogen dioxide (NO2) concentration was associated with the greatest lag-specific relative risk (RR) of gingivitis at lag 3 days (RR = 1.087, 95% CI 1.008-1.173). Fine particulate matter (PM2.5) exposure also increased the risk of periodontitis at the day of exposure (RR = 1.049, 95% CI 1.004-1.096). Elderly patients with gingivitis and periodontitis were both vulnerable to PM2.5 exposure. The interaction analyses showed that exposure to high levels of NO2 at low temperatures was related to an increased risk of gingivitis, while exposure to high levels of NO2 and PM2.5 may also increase the risk of gingivitis and periodontitis in the high-humidity environment, respectively. This study supported that NO2 and PM2.5 exposure increased the risk of gingivitis and periodontitis outpatient visits, respectively. Besides, the adverse effects of air pollutants exposure on periodontal diseases may vary depending on ambient temperature and humidity.


Asunto(s)
Contaminantes Atmosféricos , Contaminación del Aire , Gingivitis , Enfermedades Periodontales , Periodontitis , Humanos , Anciano , Dióxido de Nitrógeno/análisis , Contaminación del Aire/efectos adversos , Contaminación del Aire/análisis , Contaminantes Atmosféricos/toxicidad , Contaminantes Atmosféricos/análisis , Material Particulado/análisis , Conceptos Meteorológicos , Enfermedades Periodontales/etiología , Enfermedades Periodontales/inducido químicamente , Periodontitis/inducido químicamente , Gingivitis/inducido químicamente , Gingivitis/epidemiología , China , Exposición a Riesgos Ambientales/efectos adversos , Exposición a Riesgos Ambientales/análisis
3.
RFO UPF ; 28(1): 50-68, 20230808. tab
Artículo en Portugués | LILACS, BBO | ID: biblio-1509412

RESUMEN

Introdução: A literatura tem apontado uma possível relação entre diversas condições sistêmicas e as doenças periodontais. Dentro das doenças sistêmicas que podem gerar o uso crônico de medicamentos, com potencial associação com as doenças periodontais, destacam-se a hipercolesterolemia e o uso de estatinas; e as doenças do metabolismo ósseo e o uso de bisfosfonatos. Objetivo: Dessa maneira, o presente estudo objetivou revisar a literatura sobre o efeito das estatinas e dos bisfosfonatos nos parâmetros clínicos e radiográficos periodontais de indivíduos adultos. Resultados: Apenas estudos observacionais em humanos foram incluídos. Um estudo mostrou que, em pacientes que apresentam doença periodontal e usam estatina, houve 37% menos bolsas periodontais (profundidade de sondagem ≥4mm) quando comparadas aos que não utilizam a medicação, além de apresentarem menor índice de carga inflamatória e menor perda de inserção clínica. Em relação aos bisfosfonatos em indivíduos com doenças que envolvem o metabolismo ósseo, sugere-se que a utilização do fármaco tem obtido resultados positivos nos parâmetros periodontais, como menores sinais clínicos de inflamação gengival, menor profundidade de sondagem, menor perda de inserção clínica e maior nível de osso alveolar, quando comparados aos que nunca realizam essa terapia. Conclusão: Dessa forma, as estatinas e os bisfosfonatos apresentam efeitos promissores, em pacientes sob tratamento para suas respectivas condições sistêmicas, na melhoria dos parâmetros periodontais, porém é importante salientar que são necessários mais estudos sobre o assunto para melhor entender os reais efeitos a longo prazo do uso desses fármacos.(AU)


Introduction: The literature showed a possible relationship between several systemic conditions and periodontal diseases. Within the systemic diseases that can generate the chronic use of these drugs, potentially related with periodontal diseases, it may be cited the hypercholesterolemia and the use of statins; and bone metabolism diseases and the use of bisphosphonates. Objective: In this sense, the present study aimed to review the literature about the effect of statins and bisphosphonates in the periodontal parameters of adults individuals. Results: Only observational studies in humans were included. A study showed that, in patients with periodontal disease and users of statins, there 37% fewer periodontal pockets (probing depth ≥4mm) when compared to those who do not use the medication, as well as having a lower rate of inflammatory burden and less loss of clinical insertion. Regarding the bisphosphonates in individuals diagnosed with diseases involving bone metabolism, it was suggested that the use of the drug has obtained positive results in periodontal parameters, such as a greater absence of plaque, less clinical signs of gingival inflammation, less probing depth, lower level of clinical insertion and higher level of alveolar bone when compared to those who never undergo this therapy. Conclusion: Thus, statins and bisphosphonates have promising effects in patients under treatment for their respective systemic condition in improving periodontal parameters, but it is important to emphasize that further studies on the subject are needed to better understand the long-term effects of the use of these drugs.(AU)


Asunto(s)
Humanos , Enfermedades Periodontales/inducido químicamente , Periodoncio/efectos de los fármacos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/efectos adversos , Difosfonatos/efectos adversos , Enfermedades Óseas Metabólicas/complicaciones , Enfermedades Óseas Metabólicas/tratamiento farmacológico , Factores de Riesgo , Hipercolesterolemia/complicaciones , Hipercolesterolemia/tratamiento farmacológico
4.
BMC Womens Health ; 21(1): 48, 2021 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-33526027

RESUMEN

BACKGROUND: Previous studies indicated an impact of hormonal contraceptive use on oral health. This systematic review aimed to investigate the evidence supporting the impact of the use of hormonal contraceptives and periodontal diseases. METHODS: This study is based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and based on the PECO acrostic. Inclusion criteria comprised observational studies including women (P), which evaluated hormonal contraceptive users (E) and hormonal contraceptive non-users (C), to verify the association between this hormonal therapy and the periodontal diseases (O). Searches were performed on 5 databases: PubMed, Scopus, Web of Science, Cochrane Library, LILACS and grey literature (OpenGrey and Google Scholar). After the selection process, the included studies were evaluated qualitatively. Moreover, quantitative data were analyzed in two meta-analyses for clinical attachment loss (CAL) and probing depth (PD). Finally, the level of certainty was measured with the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) tool between periodontal clinical parameters. RESULTS: 18 articles were eligible for the qualitative synthesis and 7 of them were selected for quantitative analysis. Hence, 15 of the eligible articles reported an association between the use of hormonal contraceptives and severity of periodontal disease. However, 6 articles demonstrated high risk of bias and were excluded from quantitative synthesis. The meta-analysis showed a statistically significant difference for CAL (MD 0.24 [0.09, 0.40]; p = 0.002), but in PD (MD 0.05 [- 0.05, 0.15]; p = 0.33) such difference was not identified. A very low level of evidence was found between the clinical parameters. CONCLUSIONS: The use of hormonal contraceptives may be associated to severity of periodontal diseases. However, the quantitative analysis points to an inconclusive outcome due to the high level of heterogeneity. The association is biologically plausible, however additional studies are warranted to better elucidate the clinical significance of this possible association.


Asunto(s)
Anticonceptivos , Enfermedades Periodontales , Femenino , Humanos , Enfermedades Periodontales/inducido químicamente
5.
Biochem Pharmacol ; 182: 114286, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-33069666

RESUMEN

Nowadays, air pollution which is dominated by fine particulate matter with aerodynamic diameter less than or equal to 2.5 µm resulting from rapid industrialization and urbanization combined with population explosion has become more and more severe problem to mankind and the whole planet because of its diversity of deleterious effects. The latest data estimated that exposure to fine particulate matter, or PM2.5, contributes to approximately 4 million deaths worldwide due to cardiopulmonary conditions such as heart disease and stroke, respiratory infections, chronic lung disease and lung cancer. During recent years, there has been growing concern about the adverse effects of this global threat on oral health which is one of key components of general health and quality of life. Although a few studies have reported such possible association, the findings are still far from conclusion. Moreover, the underlying mechanisms remain unclear. To our knowledge, the analysis of literature regarding this scope has yet been published. Thus, current work systematically assesses existing evidences on the potential association between exposure to PM2.5 and the development of various oral diseases as well as figures out the plausible paradigm of PM2.5-induced damages in the oral cavity through its toxic chemical constituents along with its ability to induce oxidative stress via reactive oxygen species production. This might partially provide the clues for new research ideas and progression in the field of oral health.


Asunto(s)
Contaminantes Atmosféricos/toxicidad , Mucosa Bucal/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Material Particulado/toxicidad , Especies Reactivas de Oxígeno/metabolismo , Contaminantes Atmosféricos/química , Animales , Humanos , Mucosa Bucal/metabolismo , Mucosa Bucal/patología , Estrés Oxidativo/fisiología , Material Particulado/química , Enfermedades Periodontales/inducido químicamente , Enfermedades Periodontales/metabolismo , Enfermedades Periodontales/patología
6.
J Cancer Res Ther ; 16(3): 463-469, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32719252

RESUMEN

BACKGROUND: Tobacco practice in relation with oral diseases is a foremost cause for the global oral disease burden and is accountable for up to 50% of all periodontitis cases among adults. The present cross-sectional study was undertaken to evaluate the local effects of various types of smokeless tobacco on periodontal health in tobacco pouch keratosis (TPK) patients in Mangalore city in the state of Karnataka. MATERIALS AND METHODS: A total of 345 TPK patients were evaluated of which all were smokeless tobacco users. All the patients were clinically examined for different clinical periodontal parameters such as stains, gingival recession (GR), periodontal pocket, furcation involvement, and mobility and local effects of various types of smokeless tobacco on periodontal health in TPK sites were recorded. RESULTS: The prevalence of GR was of 87.5%. Haathichaap was the most common smokeless tobacco used (35.9%) closely followed by nonpackaged type (loose tobacco) (19.4%). This was followed by Madhu (14.2%). Likewise, periodontal parameters were observed more in these patients in decreasing order. CONCLUSION: The results of the present study agree strongly with other smokeless tobacco user studies in terms of the strong association between GR and smokeless tobacco placement. The present cross-sectional study indicates that TPK lesions are positively associated with periodontal diseases. It is important to raise awareness of both oral cancer and periodontal risks and inform about its possible health consequences thereby working towards an improvement of oral and general health and related quality of life in these patients.


Asunto(s)
Recesión Gingival/epidemiología , Queratosis/fisiopatología , Enfermedades de la Boca/epidemiología , Enfermedades Periodontales/epidemiología , Tabaco sin Humo/efectos adversos , Adolescente , Adulto , Anciano , Estudios Transversales , Femenino , Recesión Gingival/inducido químicamente , Recesión Gingival/patología , Humanos , Incidencia , India/epidemiología , Masculino , Persona de Mediana Edad , Enfermedades de la Boca/inducido químicamente , Enfermedades de la Boca/patología , Enfermedades Periodontales/inducido químicamente , Enfermedades Periodontales/patología , Calidad de Vida , Adulto Joven
7.
Molecules ; 25(6)2020 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-32197426

RESUMEN

Background: In order to identify potential activities against periodontal diseases, eighteen dihydrochalcones and structurally related compounds were tested in an established biological in vitro cell model of periodontal inflammation using human gingival fibroblasts (HGF-1 cells). Methods: Subsequently to co-incubation of HGF-1 cells with a bacterial endotoxin (Porphyromonas gingivalis lipopolysaccharide, pgLPS) and each individual dihydrochalcone in a concentration range of 1 µM to 100 µM, gene expression of interleukin-8 (IL-8) was determined by qPCR and cellular interleukin-8 (IL-8) release by ELISA. Results: Structure-activity analysis based on the dihydrochalcone backbone and various substitution patterns at its aromatic ring revealed moieties 2',4,4',6'-tetrahydroxy 3-methoxydihydrochalcone (7) to be the most effective anti-inflammatory compound, reducing the pgLPS-induced IL-8 release concentration between 1 µM and 100 µM up to 94%. In general, a 2,4,6-trihydroxy substitution at the A-ring and concomitant vanilloyl (4-hydroxy-3-methoxy) pattern at the B-ring revealed to be preferable for IL-8 release inhibition. Furthermore, the introduction of an electronegative atom in the A,B-linker chain led to an increased anti-inflammatory activity, shown by the potency of 4-hydroxybenzoic acid N-vanillylamide (13). Conclusions: Our data may be feasible to be used for further lead structure designs for the development of potent anti-inflammatory additives in oral care products.


Asunto(s)
Antiinflamatorios , Chalconas , Fibroblastos/metabolismo , Encía/metabolismo , Interleucina-8/biosíntesis , Plomo , Antiinflamatorios/química , Antiinflamatorios/farmacología , Línea Celular , Chalconas/química , Chalconas/farmacología , Fibroblastos/patología , Encía/patología , Humanos , Plomo/química , Plomo/farmacología , Lipopolisacáridos/toxicidad , Enfermedades Periodontales/inducido químicamente , Enfermedades Periodontales/tratamiento farmacológico , Enfermedades Periodontales/metabolismo , Enfermedades Periodontales/patología , Porphyromonas gingivalis/química
8.
In Vivo ; 34(1): 81-94, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31882466

RESUMEN

BACKGROUND/AIM: Microbial tetracycline (TC) pastes have been employed to treat oral bacterial infection. In the present study, we investigated the kinetic radical-scavenging and pro-/anti-inflammatory activity of TC with or without visible light irradiation (VLI). MATERIALS AND METHODS: The radical-scavenging activity of TC and minocycline (MC) was determined by differential scanning calorimetry (DSC). The stoichiometric factor (n) and the rate constant of inhibition and propagation (kinh/kp) were determined. The levels of cyclooxygenase-2 (Cox2), tumor necrosis factor-α (Tnfα) or nitric oxide synthase 2 (Nos2) mRNA in RAW264.7 cells stimulated with lipopolysaccharide (LPS) were investigated using real-time reverse transcriptase-polymerase chain reaction. RESULTS: The n and kinh/kp values for 1 mM TC in 2,2'-azobisisobutyronitrile and benzoyl peroxide systems were 0.1-0.2 and 119-250, respectively, whereas the corresponding values for quercetin (QU) and resveratrol (RE) were 2-4 and 7-15, respectively. In RAW264.7 cells stimulated with LPS, Cox2 and Tnfα mRNA were over-expressed in the presence of TC. MC down-regulated only the expression of Cox2 by about 50% in LPS-stimulated cells. The anti-inflammatory activity determined on the basis of Cox2 inhibition declined in the order QU>RE>MC>TC. Upon application of VLI, only TC down-regulated the expression of LPS-stimulated Cox2 and Tnfα mRNA. After exposure to VLI, TC, but not MC, markedly up-regulated hemoxygenase-1 (Ho-1) expression. CONCLUSION: TC is a chain-breaking antioxidant with a large kinh Upon activation by VLI, TC may undergo degradation and its degradation products affect pleiotropic mediators such as Cox2, Tnfα and Ho-1. TC may be useful as a local photodynamic therapy for periodontal diseases.


Asunto(s)
Antiinflamatorios/farmacología , Fenoles/farmacología , Tetraciclinas/farmacología , Animales , Antibacterianos/metabolismo , Antibacterianos/farmacología , Antioxidantes/metabolismo , Línea Celular , Ciclooxigenasa 2/metabolismo , Inhibidores de la Ciclooxigenasa 2/farmacología , Regulación hacia Abajo/efectos de los fármacos , Depuradores de Radicales Libres/farmacología , Hemo-Oxigenasa 1/metabolismo , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Ratones , Óxido Nítrico Sintasa de Tipo II/metabolismo , Enfermedades Periodontales/inducido químicamente , Enfermedades Periodontales/tratamiento farmacológico , Enfermedades Periodontales/metabolismo , Quercetina/farmacología , Células RAW 264.7 , ARN Mensajero/metabolismo , Resveratrol/farmacología , Factor de Necrosis Tumoral alfa/metabolismo , Regulación hacia Arriba/efectos de los fármacos
9.
Support Care Cancer ; 28(1): 177-184, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31001696

RESUMEN

PURPOSE: Crevicular fluid was used to assess interleukin-17 (IL-17) and vascular endothelial growth factor (VEGF) in cancer patients receiving zoledronic acid and/or bevacizumab. The markers were also assessed in the serum. METHODS: Twenty-five patients were included and comprised three groups: patients who received zoledronic acid (n = 9), patients who received bevacizumab (n = 9), and patients who received zoledronic acid combined with bevacizumab (n = 5). One patient received zoledronic acid and everolimus and another received zoledronic acid, bevacizumab, and temsirolimus. IL-17 and VEGF were measured by standard quantitative ELISA kits and assessed in two study points. RESULTS: Twenty-four patients maintained good periodontal health; one had asymptomatic osteonecrosis of the jaw. First assessment: 44 samples were collected; 21 from serum and 23 from crevicular fluid. Second assessment, 6 months later: 11 samples were collected; 6 from serum and 5 from crevicular fluid. IL-17 was detected in all samples, in serum and crevicular fluid, and remained unchanged at both time points. Serum VEGF in patients with bevacizumab alone or combined with zoledronic acid was significantly lower compared with that of patients who received zoledronic acid alone. VEGF was not detected in the crevicular fluid. CONCLUSIONS: Crevicular fluid might be an easy, non-invasive means to assess IL-17. The stable values of IL-17 in crevicular fluid and serum and the lack of VEGF in the crevicular fluid could be related to the good periodontal health of our patients. Further studies are needed to assess IL-17 and VEGF in the crevicular fluid in patients with and without periodontal disease.


Asunto(s)
Bevacizumab/administración & dosificación , Líquido del Surco Gingival/química , Interleucina-17/análisis , Neoplasias/tratamiento farmacológico , Enfermedades Periodontales/diagnóstico , Factor A de Crecimiento Endotelial Vascular/análisis , Ácido Zoledrónico/administración & dosificación , Anciano , Anciano de 80 o más Años , Bevacizumab/efectos adversos , Biomarcadores/análisis , Biomarcadores/metabolismo , Quimioterapia Combinada/efectos adversos , Femenino , Líquido del Surco Gingival/metabolismo , Humanos , Inflamación/diagnóstico , Inflamación/metabolismo , Interleucina-17/metabolismo , Masculino , Persona de Mediana Edad , Neoplasias/irrigación sanguínea , Neoplasias/metabolismo , Neoplasias/patología , Neovascularización Patológica/diagnóstico , Neovascularización Patológica/metabolismo , Osteonecrosis/inducido químicamente , Osteonecrosis/diagnóstico , Osteonecrosis/metabolismo , Enfermedades Periodontales/inducido químicamente , Enfermedades Periodontales/etiología , Bolsa Periodontal/inducido químicamente , Bolsa Periodontal/diagnóstico , Bolsa Periodontal/metabolismo , Valor Predictivo de las Pruebas , Factor A de Crecimiento Endotelial Vascular/metabolismo , Ácido Zoledrónico/efectos adversos
10.
Afr Health Sci ; 19(1): 1795-1800, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31149010

RESUMEN

BACKGROUND: Oral contraceptives pills (OCPs) are common and a convenient form of contraception. The use of hormonal contraceptives by women has been considered to influence gingival and periodontal disease progression. AIM: This study was conducted to assess the effect of oral contraceptive pills on the periodontal health. MATERIALS AND METHOD: A cross-sectional comparative study was conducted among 200 females aged 18 years and above of Jaipur city. The study subjects were divided into two groups i.e. contraceptive users and non-contraceptive users, each group consisted 100 females. Data was collected using Modified WHO Performa (1997). Periodontal status was examined using Community Periodontal Index (CPI) and Loss of Attachment (LOA). Chi-square test and one sample t-test was used for statistical analysis and P value was set (p< 0.05) as significant. RESULTS: Mean CPI score in subjects and non-contraceptive users was 2.34+ 0.81 and 1.16+ 0.89 respectively. Mean LOA score in each group was 0.28+ 0.45 and 0.19+ 0.50 respectively. CONCLUSION: Oral Contraceptive pills had adverse effects on periodontal health.


Asunto(s)
Anticonceptivos Orales/administración & dosificación , Gingivitis/inducido químicamente , Pérdida de la Inserción Periodontal/inducido químicamente , Enfermedades Periodontales/inducido químicamente , Periodontitis/inducido químicamente , Periodoncio/efectos de los fármacos , Adolescente , Adulto , Estudios de Casos y Controles , Anticonceptivos Orales/efectos adversos , Estudios Transversales , Índice de Placa Dental , Femenino , Gingivitis/epidemiología , Humanos , India/epidemiología , Pérdida de la Inserción Periodontal/epidemiología , Enfermedades Periodontales/epidemiología , Índice Periodontal , Bolsa Periodontal , Periodontitis/epidemiología , Prevalencia , Adulto Joven
11.
Support Care Cancer ; 27(9): 3479-3490, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30675665

RESUMEN

PURPOSE: To determine the prevalence of professionally reported oral side effects of chemotherapy and the self-reported oral side effects and whether both prevalences could be related to the periodontal risk of the patients. METHODS: A cross-sectional study with patients undergoing chemotherapy treatment was carried out. Demographic, oral hygiene habits, and cancer-related data were collected while the patient was receiving the chemotherapy infusion. Patient's oral status, measured according to the oral-assessment guide for patients in hospital environments, patient-related outcomes (PROMs), measured by a visual analogue scale, and patient's periodontal risk were analyzed using validated questionnaires. Data was reported in means and standard deviations (SD) in quantitative variables and in counts, prevalence, and 95% confidence intervals (CI) in qualitative variables. ANOVA test and chi-squared tests were used to compare oral side effects among different periodontal risk groups. RESULTS: Three hundred sixty-nine patients were included in the study. The prevalence of professionally reported oral side effects was 86.99% (95% confidence interval CI 83.54%; 90.44%). The prevalence of self-reported oral side effects was 89.70% (95% CI 86.59; 92.82). The most common oral side effects were xerostomia (73.4%), dysgeusia (61.8%), and dry lips (54.2%). More oral alterations were found in patients with worse periodontal risk (p < 0.001). CONCLUSIONS: The prevalence of oral side effects (professional or self-reported) is higher than 85% in patients undergoing chemotherapy. This prevalence increases as the risk of developing periodontal disease does.


Asunto(s)
Antineoplásicos/efectos adversos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/epidemiología , Disgeusia/epidemiología , Enfermedades Periodontales/epidemiología , Xerostomía/epidemiología , Adulto , Anciano , Antineoplásicos/uso terapéutico , Estudios Transversales , Disgeusia/inducido químicamente , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias/tratamiento farmacológico , Higiene Bucal , Enfermedades Periodontales/inducido químicamente , Prevalencia , Factores de Riesgo , Autoinforme , España/epidemiología , Encuestas y Cuestionarios , Xerostomía/inducido químicamente
13.
Int. j. odontostomatol. (Print) ; 12(3): 287-295, Sept. 2018. tab
Artículo en Español | LILACS | ID: biblio-975747

RESUMEN

RESUMEN: Los dispositivos de administración electrónica de nicotina aparecieron con el objetivo de reemplazar el uso del tabaco y contribuir al reciente crecimiento de las políticas antitabaco. Actualmente, los efectos que producen los químicos que contiene son desconocidos. El objetivo de este trabajo consistió en describir la información encontrada en la literatura sobre los posibles daños generados por los dispositivos de administración electrónica de nicotina, en la cavidad bucal y los tejidos periodontales. Se realizó una búsqueda electrónica y manual, sin límite de idioma ni año. Se excluyeron, opiniones de expertos y artículos que estudiaran otros dispositivos de administración de nicotina. Se seleccionaron 18 artículos, 7 estudios in-vitro, 2 estudios longitudinales, 2 ensayos clínicos y 7 reportes de caso. Se encontró que existen niveles de citotoxicidad elevados, observando cambios a nivel de morfología y metabolismo celular. Sin embargo, si lo comparamos con el tabaco, se observa que los niveles de toxicidad son menores en los dispositivos de administración electrónica de nicotina. En los estudios longitudinales y ensayos clínicos se observó un aumento del sangramiento al sondaje y de la circulación sanguínea, medida con láser Doppler, al cambiar de cigarro convencional a cigarro electrónico. Los reportes de caso informan de importantes traumatismos en el territorio maxilofacial, causados por la explosión de estos dispositivos, durante su uso. Los dispositivos de administración electrónica de nicotina son tóxicos a nivel de las células periodontales, generando necrosis y daños al ADN celular. Presentan riesgos de uso, reportándose traumatismos graves a nivel oral y maxilofacial, por sobrecalentamiento de las baterías. Los ensayos clínicos y estudios longitudinales no fueron concluyentes, por lo que se debe seguir investigando en la materia.


ABSTRACT: Electronic nicotine delivery systems were introduced to replace tobacco use and contribute to the anti-smoking policies. Today, the effect the chemicals it contains produce in the human body, are unknown. The aim of this work was to describe the information found in the literature about the possible damage produced in the periodontal tissue and the oral cavity, by the electronic nicotine delivery systems. An electronic and manual search was carried by a single reviewer, without year or language limit, excluding expert's opinions and articles that studied other nicotine delivery systems. Eighteen articles were selected; 7 in vitro studies, 2 longitudinal studies, 2 clinical trials and 7 case reports. Toxicity levels were found to be high, showing changes in cellular morphology and metabolism. Comparing with conventional cigarette, toxicity levels were lower in the electronic nicotine delivery systems. Longitudinal studies and clinical trials observed an increase in bleeding on probing and in blood circulation, by using laser doppler velocimetry, when changing from conventional cigarette to electronic cigarette. Also reports about explosions while using these electronic devises were encountered in the literature, with grave consequences in the maxillofacial territory. Electronic nicotine delivery systems show toxic levels, generating necrosis and DNA damage in periodontal ligament and gingival fibroblast cells. The risk of using these devices is high, due to possible explosion following overheating of the lithium battery, causing facial and oral trauma. Clinical trials and longitudinal studies were not conclusive, so investigations should continue in this matter.


Asunto(s)
Humanos , Enfermedades Periodontales/inducido químicamente , Nicotina/efectos adversos , Nicotina/farmacología , Sistemas Electrónicos de Liberación de Nicotina , Boca
14.
J Med Food ; 21(10): 961-970, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30088980

RESUMEN

Periodontitis, an inflammatory disease of the gingival tissue, triggered by microbial-derived elements, such as lipopolysaccharide (LPS), collapses the periodontal tissues and resorbs the alveolar bone. This study evaluated the inhibitory effects of standardized Boesenbergia pandurata extract (BPE) and panduratin A (PAN) on periodontitis-induced inflammation and alveolar bone loss. Sprague-Dawley rats with LPS-induced periodontitis were orally administered BPE (50 and 200 mg/kg/day) and PAN (20 mg/kg/day) for 8 days. Histological analysis revealed that BPE- and PAN-administered groups showed decreased cell infiltration and alveolar bone resorption. Furthermore, the BPE and PAN significantly alleviated the mRNA and protein expression levels of nuclear factor kappa B (NF-κB), interleukin-1ß, matrix metalloproteinase (MMP)-2, and MMP-8. BPE and PAN also inhibited the expression of nuclear factor of activated T cells, cytoplasmic 1, c-Fos, and ostoclastogenesis-related enzymes, including cathepsin K and tartrate-resistant acid phosphatase (ALP). BPE and PAN not only upregulated the osteoblastogenesis-associated markers, such as collagen type I (COL1A1) and ALP, but also increased the ratio of osteoprotegerin to receptor activator of NF-κB ligand. Collectively, BPE and PAN efficiently prevent destruction of periodontal tissues and stimulating the loss of alveolar bone tissues, strongly indicative of their potential as natural antiperiodontitis agents.


Asunto(s)
Pérdida de Hueso Alveolar/tratamiento farmacológico , Chalconas/administración & dosificación , Enfermedades Periodontales/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , Zingiberaceae/química , Pérdida de Hueso Alveolar/inducido químicamente , Pérdida de Hueso Alveolar/inmunología , Animales , Chalconas/química , Colágeno Tipo I/genética , Colágeno Tipo I/inmunología , Humanos , Interleucina-1beta/genética , Interleucina-1beta/inmunología , Lipopolisacáridos/efectos adversos , Masculino , Metaloproteinasa 2 de la Matriz/genética , Metaloproteinasa 2 de la Matriz/inmunología , FN-kappa B/genética , FN-kappa B/inmunología , Osteoprotegerina/genética , Osteoprotegerina/inmunología , Enfermedades Periodontales/inducido químicamente , Enfermedades Periodontales/inmunología , Extractos Vegetales/química , Ratas , Ratas Sprague-Dawley
15.
Sci Rep ; 8(1): 11055, 2018 07 23.
Artículo en Inglés | MEDLINE | ID: mdl-30038248

RESUMEN

The aim of this study was to evaluate the associations between cigarette use and five salivary oxidative stress biomarkers, copper-zinc superoxide dismutase (Cu/Zn SOD), manganese superoxide dismutase (MnSOD), catalase, thioredoxin-1 (TRX1), and peroxiredoxin-2 (PRX2), to assess the effectiveness of non-surgical periodontal therapy. MATERIALS AND METHODS: This is an observational study,167 patients diagnosed with periodontitis were recruited. Both saliva samples and clinical measurements (plaque index (PI), bleeding on probing (BOP), and pocket depth (PD)) were taken at baseline and after completing non-surgical periodontal therapy. The Levels of salivary biomarkers were determined using a MILLIPLEX® MAP Human Oxidative Stress Magnetic Bead Panel kit. The overall reductions in PI and BOP were 31.56% and 42.16%, respectively. BOP reduction after treatment in female or male non-smokers was significantly higher than in male former smokers (p < 0.05). After completing non-surgical periodontal therapy, Cu/ZnSOD, MnSOD, catalase, and Prx2 significantly decreased. There was a significant interaction between smoking status and ΔCu/ZnSOD on PI and a significant interaction between smoking status and ΔCatalase on BOP. CONCLUSIONS: Cigarette smoking interferes with redox homeostasis in the body, alters antioxidants levels, and influences the periodontal disease activity.


Asunto(s)
Fumar Cigarrillos/efectos adversos , Enfermedades Periodontales/metabolismo , Anciano , Femenino , Homeostasis/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Estudios Observacionales como Asunto , Oxidación-Reducción/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Enfermedades Periodontales/inducido químicamente
16.
J Cell Physiol ; 233(10): 6734-6747, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-29600566

RESUMEN

In the present study we have mimicked, in vitro, an inflammatory process using Lipopolysaccharide derived from Porphyromonas Gingivalis (LPS-G) and human Periodontal Ligament Stem Cells induced to endothelial differentiation (e-hPDLSCs). The research project has been organized into the three following steps: i) induction of hPDLSCs toward endothelial differentiation; ii) evaluation of the molecular signaling pathway involved in the response to the LPS-G, and iii) functional response evaluation of the living construct constituted by porcine decellularized valve/e-hPDLSCs treated with LPS-G. Obtained results showed that 5 µg/ml LPS-G stimulus provokes: a slowdown of cell growth starting from 24 hr and the release of IL6, IL8, and MCP1 molecules. Signaling network analyzed showed the activation of TLR4/ NFkB/ERK1/2/p-ERK1/2 signaling mediated by MyD88 in LPS-G stimulated e-hPDLSCs, moreover a time course put in evidence a nuclear traslocation of ERK1/2 and p-ERK1/2 in differentiated samples. Following, the ability of e-hPDLSCs to expand and colonize the decellularized porcine heart valves was appraised at ultrastructural level. Considering that, the Reactive Oxygen Species (ROS) play an important role in the progression and development of cardiovascular disease (CVD), in LPS-G living construct model e-hPDLSCs/decellularized porcine heart valves (dPHV), ROS production was assessed. Time lapse experiments evidenced that LPS-G provokes in e-hPDLSCs a rapid and sustained increase in ROS generation, negligible on undifferentiated cells. From obtained data, by multiparametric analyses, a reasonable conclusion may be that the inflammation process activated by LPS-G can affect endothelial cells and could represent in vivo a possible pathological and predictor state of CVD.


Asunto(s)
Enfermedades Cardiovasculares/genética , Inflamación/genética , Enfermedades Periodontales/genética , Células Madre/citología , Animales , Enfermedades Cardiovasculares/inducido químicamente , Enfermedades Cardiovasculares/complicaciones , Enfermedades Cardiovasculares/patología , Diferenciación Celular/genética , Células Endoteliales/metabolismo , Células Endoteliales/patología , Válvulas Cardíacas/crecimiento & desarrollo , Válvulas Cardíacas/patología , Humanos , Inflamación/inducido químicamente , Inflamación/complicaciones , Inflamación/patología , Lipopolisacáridos/toxicidad , Sistema de Señalización de MAP Quinasas/genética , Factor 88 de Diferenciación Mieloide/genética , FN-kappa B/genética , Enfermedades Periodontales/inducido químicamente , Enfermedades Periodontales/complicaciones , Enfermedades Periodontales/patología , Ligamento Periodontal/citología , Ligamento Periodontal/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Células Madre/patología , Porcinos , Receptor Toll-Like 4/genética
17.
Arch Oral Biol ; 89: 44-48, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29448184

RESUMEN

OBJECTIVE: This study evaluated the effect of an experimental carcinogenic, 4-Nitroquinoline 1-oxide (4NQO), in the spontaneous alveolar bone loss (ABL) in an animal model. DESIGN: Twenty-two male Wistar rats were included in this study. They were randomly divided into two groups: the control group (n = 10) received food and water ad libitum, and the test group (n = 12) receive the same food; however, 25 ppm of 4NQO was diluted in the drinking water. All animals were euthanized after 20 weeks, and the tongues were removed and analyzed macroscopically to determine the presence of oral mucosal lesions. All specimens were paraffin-embedded and histological sections were obtained. The microscopic analysis was based on routine procedure (haematoxylin and eosin stain). The analysis of spontaneous ABL was performed by a calibrated examiner using standardized photographs and imaging software. Differences in spontaneous ABL were assessed among the three resulting groups: control, 4NQO with oral squamous cell carcinoma (OSCC), and 4NQO without OSCC. RESULTS: In the 4NQO-treated group, nine animals developed OSCC. The animals in the 4NQO with OSCC group presented significantly more spontaneous ABL (0.65 ±â€¯0.21 mm) than the control group (0.34 ±â€¯0.05) (p < 0.001). The animals in the 4NQO without OSCC group showed a mean spontaneous ABL of 0.47 ±â€¯0.13 mm, which was not statistically significant different when compared to the control group (p = 0.096). CONCLUSIONS: It was concluded that the presence of OSCC enhanced spontaneous ABL in Wistar rats when compared to control animals. Additionally, it was shown that, solely, administration of 4NQO may not be considered responsible for alveolar bone destruction.


Asunto(s)
4-Nitroquinolina-1-Óxido/farmacología , Pérdida de Hueso Alveolar/inducido químicamente , Pérdida de Hueso Alveolar/patología , Animales , Carcinogénesis , Carcinógenos , Carcinoma de Células Escamosas/inducido químicamente , Carcinoma de Células Escamosas/patología , Modelos Animales de Enfermedad , Ingestión de Líquidos , Masculino , Neoplasias de la Boca/inducido químicamente , Neoplasias de la Boca/patología , Enfermedades Periodontales/inducido químicamente , Ratas , Ratas Wistar , Lengua
18.
J Investig Clin Dent ; 9(1)2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28834423

RESUMEN

Khat or qat (Catha edulis) is a plant that grows in East Africa and southern Arabia. The leaves and twigs of this small tree are chewed by several millions of people worldwide for their stimulating amphetamine-like effects. The reported prevalence of khat chewing in Europe and the USA is on the rise, especially with global migration. Long-term khat chewing has several detrimental general and oral health effects. The aim of the present study was to review the current literature regarding khat use and its association with oral and dental diseases, with particular emphasis on its link with oral keratotic white lesions and oral cancer. We searched the literature to identify all relevant articles. Studies showed that khat is associated with several oral and dental conditions, including keratotic white lesions, mucosal pigmentation, periodontal disease, tooth loss, plasma cell stomatitis, and xerostomia. There are limited data on the incidence of dental caries among khat chewers. The evidence that khat chewing is a risk factor for oral cancer is still weak, and is mainly based on anecdotal case reports and uncontrolled studies.


Asunto(s)
Catha/efectos adversos , Salud Bucal , Extractos Vegetales/efectos adversos , Anfetamina/efectos adversos , Caries Dental/inducido químicamente , Gingivitis/inducido químicamente , Humanos , Masticación , Microbiota/efectos de los fármacos , Mucosa Bucal/efectos de los fármacos , Neoplasias de la Boca/inducido químicamente , Enfermedades Periodontales/inducido químicamente , Periodoncio/efectos de los fármacos , Pigmentación/efectos de los fármacos , Hojas de la Planta/química , Factores de Riesgo , Glándulas Salivales/efectos de los fármacos , Estomatitis/inducido químicamente , Trastornos de la Articulación Temporomandibular/inducido químicamente , Uso de Tabaco/efectos adversos , Decoloración de Dientes/inducido químicamente , Pérdida de Diente/inducido químicamente , Xerostomía/inducido químicamente
20.
Clin Calcium ; 27(10): 1417-1425, 2017.
Artículo en Japonés | MEDLINE | ID: mdl-28947693

RESUMEN

The field of special care dentistry is rapidly gaining recognition as a service that should be provided to the persons with physical, mental or intellectual disabilities by general practitioner, pediatric or geriatric dentists as well as dental hygienists. Because the oral healthcare and dental treatments are given in the narrow space of oral cavity and also accompanying technical difficulties with high risk of injury, the special needs patients are treated under being controlled their behavior or body motion by applying psychological, physical or pharmacological techniques. Those persons also manifest specific oral signs and symptoms such as dental caries, periodontal diseases as well as high incidence of dental hypoplasia, oro-facial trauma or drug-induced gingival overgrowth. The children with developmental disorders especially such as autism spectrum disorder(ASD), attention-deficit/hyperactivity disorder(AD/HD), or specific learning disorder(LD), and those with medical care needs at all times are also increasing relatively in Japan with declining birthrate. Those children have specific dental problems and require the special oral healthcare. This article presents the current status of oral healthcare for the persons with special needs.


Asunto(s)
Atención Dental para la Persona con Discapacidad , Enfermedades Periodontales/terapia , Calcio/metabolismo , Humanos , Protectores Bucales , Enfermedades Periodontales/inducido químicamente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA